The new QST bioassay laboratory in Chiba Japan
The new QST bioassay laboratory in Chiba Japan
复制标题
日本千叶新的 QST 生物测定实验室
DOI:
10.1093/rpd/ncac198
复制
发表时间:
2022
影响因子:
1
通讯作者:
Guosheng Yang; Kotaro Tani; Munehiko Kowatari; Yuki Tamakuma; Masayuki Naito; Eunjoo Kim; Osamu Kurihara
中科院分区:
文献类型:
--
作者:
Gohara S;Shinohara K;Yoshida R;Kariya R;Tazawa H;Hashimoto M;Inoue J;Kubo R;Nakashima H;Arita H;Kawaguchi S;Yamana K;Nagao Y;Iwamoto A;Sakata J;Matsuoka Y;Takeshita H;Hirayama M;Kawahara K;Nagata M;Hirosue A;Kuwahara Y;Fukumoto M;Ok;Guosheng Yang; Jian Zheng; Munehiko Kowatari; Eunjoo Kim; Osamu Kurihara;Guosheng Yang; Kotaro Tani; Munehiko Kowatari; Yuki Tamakuma; Masayuki Naito; Eunjoo Kim; Osamu Kurihara
Japan’s National Institutes for Quantum Science and Technology (QST) was designated as the core radiation emergency medical support center by the country’s Nuclear Regulation Authority (NRA) in 2019. One of the main missions of the QST is to maintain and improve its dose assessment capability for radiation-exposed individuals. Toward the goal of effectively fulfilling this mission, a new facility—the Dose Assessment Building for Advanced Radiation Emergency Medicine—was constructed at the Chiba base of the QST in 2020. An integrated bioassay laboratory was installed in this facility for assessing subjects’ internal doses, along with a new integratedin vivocounter. The bioassay capability of the new laboratory is currently expected to screen 5–10 persons simultaneously assuming internal contamination with actinides such as Pu, Am/Cm and U, although this is dependent on the specific contamination circumstances.